Market capitalization | $632.93m |
Enterprise Value | $330.45m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 15.22 |
P/S ratio (TTM) P/S ratio | 29.15 |
P/B ratio (TTM) P/B ratio | 1.85 |
Revenue growth (TTM) Revenue growth | -27.63% |
Revenue (TTM) Revenue | $21.71m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast Exscientia:
1 Analyst has issued a forecast Exscientia:
Sep '24 |
+/-
%
|
||
Revenue | 22 22 |
28%
28%
|
|
Gross Profit | -38 -38 |
53%
53%
|
|
EBITDA | -198 -198 |
4%
4%
|
EBIT (Operating Income) EBIT | -222 -222 |
1%
1%
|
Net Profit | -191 -191 |
9%
9%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.
Head office | United Kingdom |
CEO | David Hallett |
Employees | 483 |
Founded | 2012 |
Website | www.exscientia.ai |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.